From structure and functions of steroidogenic enzymes to new technologies of gene engineering

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Biochemistry (Moscow)

• Publication date

  2009-12-01

• Fields of study

  Biology, Medicine, Engineering

• Identifiers
  DOI 10.1134/S0006297909130057PMID 20210705
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Aconitase overexpression changes the product ratio of citric acid production by Yarrowia lipolytica

  2009cited by this paper
• Synthesis, biological evaluation and molecular modelling studies of methyleneimidazole substituted biaryls as inhibitors of human 17alpha-hydroxylase-17,20-lyase (CYP17). Part I: Heterocyclic modifications of the core structure.

  2008cited by this paper
• Import of hybrid forms of CYP11A1 into yeast mitochondria.

  2008cited by this paper
• Synthesis, biological evaluation and molecular modelling studies of novel ACD- and ABD-ring steroidomimetics as inhibitors of CYP17.

  2008cited by this paper
• Development of an adrenocorticotropin-responsive human adrenocortical carcinoma cell line.

  2008cited by this paper
• Targeting cytochrome P450 enzymes: a new approach in anti-cancer drug development.

  2007cited by this paper
• Cytochrome P450 side-chain cleavage: insights gained from homology modeling.

  2007cited by this paper
• Comparative study of topogenesis of cytochrome P450scc (CYP11A1) and its hybrids with adrenodoxin expressed in Escherichia coli cells

  2007cited by this paper
• A novel vector element providing multicopy vector integration in Arxula adeninivorans.

  2007cited by this paper
• Transcriptional Regulation of Adrenocortical Steroidogenic Gene Expression

  2007cited by this paper
• A dynamic machinery for import of mitochondrial precursor proteins

  2007cited by this paper
• Range of substrates and steroid bioconversion reactions performed by recombinant microorganisms Saccharomyces cerevisiae and Yarrowia lipolytica expressing cytochrome P450c17

  2006cited by this paper
• [Effect of steroid biosynthesis modificators on the progesterone biotransformation by a recombinant yeasts expressing cytochrome P450c17].

  2006cited by this paper
• A fission yeast-based test system for the determination of IC50 values of anti-prostate tumor drugs acting on CYP21

  2006cited by this paper
• Expression of cytochrome P450scc in Escherichia coli cells: Intracellular location and interaction with bacterial redox proteins

  2006cited by this paper
• CYP17- and CYP11B-dependent steroid hydroxylases as drug development targets.

  2006cited by this paper
• CYP24, the enzyme that catabolizes the antiproliferative agent vitamin D, is increased in lung cancer

  2006cited by this paper
• Coexpression of all constituents of the cholesterol hydroxylase/lyase system in Escherichia coli cells

  2006cited by this paper
• Benzofuran- and furan-2-yl-(phenyl)-3-pyridylmethanols: Synthesis and inhibition of P450 aromatase

  2005cited by this paper
• Homology modeling of cytochrome P450scc and the mutations for optimal amperometric sensor.

  2005cited by this paper
• The adrenocortical tumor cell line NCI-H295R as an in vitro screening system for the evaluation of CYP11B2 (aldosterone synthase) and CYP11B1 (steroid-11beta-hydroxylase) inhibitors.

  2005cited by this paper
• Synthesis and anti-aromatase activity of some new steroidal D-lactones.

  2005cited by this paper
• Novel C-17-heteroaryl steroidal CYP17 inhibitors/antiandrogens: synthesis, in vitro biological activity, pharmacokinetics, and antitumor activity in the LAPC4 human prostate cancer xenograft model.

  2005cited by this paper
• Minireview: regulation of steroidogenesis by electron transfer.

  2005cited by this paper
• Synthesis and evaluation of (pyridylmethylene)tetrahydronaphthalenes/-indanes and structurally modified derivatives: potent and selective inhibitors of aldosterone synthase.

  2005cited by this paper
• Synthesis and evaluation of imidazolylmethylenetetrahydronaphthalenes and imidazolylmethyleneindanes: potent inhibitors of aldosterone synthase.

  2005cited by this paper
• Hydrophobic substrate utilisation by the yeast Yarrowia lipolytica, and its potential applications.

  2005cited by this paper
• Aromatase inhibitors in the treatment of breast cancer.

  2005cited by this paper
• Structural basis for the role in protein folding of conserved proline-rich regions in cytochromes P450.

  2004cited by this paper
• Models and mechanisms of O-O bond activation by cytochrome P450. A critical assessment of the potential role of multiple active intermediates in oxidative catalysis.

  2004cited by this paper
• Putative F-G loop is involved in association with the membrane in P450scc (P450 11A1).

  2004cited by this paper
• Potent, low-calcemic, selective inhibitors of CYP24 hydroxylase: 24-sulfone analogs of the hormone 1α,25-dihydroxyvitamin D3 ☆

  2004cited by this paper
• Development of test systems for the discovery of selective human aldosterone synthase (CYP11B2) and 11beta-hydroxylase (CYP11B1) inhibitors. Discovery of a new lead compound for the therapy of congestive heart failure, myocardial fibrosis and hypertension.

  2004cited by this paper
• Expression of human cytochrome P450 46A1 in Escherichia coli: effects of N- and C-terminal modifications.

  2004cited by this paper
• Synthesis and biological evaluation of 4-imidazolylflavans as nonsteroidal aromatase inhibitors.

  2004cited by this paper
• The adrenodoxin-like ferredoxin of Schizosaccharomyces pombe mitochondria.

  2004cited by this paper
• CYP 17 and CYP 19 Inhibitors. Evaluation of Fluorine Effects on the Inhibiting Activity of Regioselectively Fluorinated 1-(Naphthalen-2-ylmethyl)imidazoles

  2004cited by this paper
• Potent CYP17 inhibitors: improved syntheses, pharmacokinetics and anti-tumor activity in the LNCaP human prostate cancer model.

  2004cited by this paper
• Human hepatocytes in primary culture: the choice to investigate drug metabolism in man.

  2004cited by this paper
• Synthesis and CYP24 inhibitory activity of 2-substituted-3,4-dihydro-2H-naphthalen-1-one (tetralone) derivatives.

  2004cited by this paper
• Hormonal impact of the 17α-hydroxylase/C17,20-lyase inhibitor abiraterone acetate (CB7630) in patients with prostate cancer

  2004cited by this paper
• C17,20-lyase inhibitors I. Structure-based de novo design and SAR study of C17,20-lyase inhibitors.

  2004cited by this paper
• Purification and characterization of mouse CYP27B1 overproduced by an Escherichia coli system coexpressing molecular chaperonins GroEL/ES.

  2004cited by this paper
• Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones.

  2004cited by this paper
• Synthesis of 21,21-difluoro-3 beta-hydroxy-20-methylpregna-5,20-diene and 5,16,20-triene as potential inhibitors of steroid C17(20) lyase.

  2003cited by this paper
• Effects of various N-terminal addressing signals on sorting and folding of mammalian CYP11A1 in yeast mitochondria.

  2003cited by this paper
• Global incorporation of norleucine in place of methionine in cytochrome P450 BM‐3 heme domain increases peroxygenase activity

  2003cited by this paper
• Total biosynthesis of hydrocortisone from a simple carbon source in yeast

  2003cited by this paper
• 5alpha-reduced C21 steroids are substrates for human cytochrome P450c17.

  2003cited by this paper
• 5α-reduced C21 steroids are substrates for human cytochrome P450c17

  2003cited by this paper
• Formation and Functioning of Fused Cholesterol Side-Chain Cleavage Enzymes

  2003cited by this paper
• Novel P450(17alpha) inhibitors: 17-(2'-oxazolyl)- and 17-(2'-thiazolyl)-androstene derivatives.

  2003cited by this paper
• Novel P45017α inhibitors: 17-(2′-oxazolyl)- and 17-(2′-thiazolyl)-androstene derivatives

  2003cited by this paper
• Intracellular Expression of Peptide Fusions for Demonstration of Protein Essentiality in Bacteria

  2003cited by this paper
• The F-G loop region of cytochrome P450scc (CYP11A1) interacts with the phospholipid membrane.

  2003cited by this paper
• Aromatase inhibitors in breast cancer.

  2003cited by this paper
• [Oxidation of 17alpha,20beta- and 17alpha,20alpha-dihydroxysipregn-4-en-ones--side products of biotransformation of progesterone by recombinant microorganisms expressing cytochrome P45017alpha].

  2003cited by this paper
• Biotransformation of Steroids by a Recombinant Yeast Strain Expressing Bovine Cytochrome P-45017α

  2002cited by this paper
• Import and assembly of proteins into mitochondria of mammalian cells.

  2002cited by this paper
• Development of a test system for inhibitors of human aldosterone synthase (CYP11B2): screening in fission yeast and evaluation of selectivity in V79 cells.

  2002cited by this paper
• Electron acceptor specificity of ferredoxin (flavodoxin):NADP+ oxidoreductase from Escherichia coli.

  2002cited by this paper
• Biodegradation of polychlorinated dibenzo-p-dioxins by recombinant yeast expressing rat CYP1A subfamily.

  2002cited by this paper
• Rapid regulation of steroidogenesis by mitochondrial protein import

  2002cited by this paper
• Probing the interaction of bovine cytochrome P450scc (CYP11A1) with adrenodoxin: evaluating site-directed mutations by molecular modeling.

  2002cited by this paper
• Mechanism-based inactivation of cytochrome P450 3A4 by 17 alpha-ethynylestradiol: evidence for heme destruction and covalent binding to protein.

  2002cited by this paper
• Genetically engineered bacterial cells co-expressing human cytochrome P450 with NADPH-cytochrome P450 reductase: prediction of metabolism and toxicity of drugs in humans.

  2002cited by this paper
• Dehydroepiandrosterone (DHEA) metabolism in Saccharomyces cerevisiae expressing mammalian steroid hydroxylase CYP7B: Ayr1p and Fox2p display 17β‐hydroxysteroid dehydrogenase activity

  2002cited by this paper
• Preclinical activity of ketoconazole in combination with calcitriol or the vitamin D analogue EB 1089 in prostate cancer cells.

  2002cited by this paper
• Membrane Binding and Substrate Access Merge in Cytochrome P450 7A1, a Key Enzyme in Degradation of Cholesterol*

  2001cited by this paper
• Covalently crosslinked complexes of bovine adrenodoxin with adrenodoxin reductase and cytochrome P450scc. Mass spectrometry and Edman degradation of complexes of the steroidogenic hydroxylase system.

  2001cited by this paper
• Mapping the interactions between flavodoxin and its physiological partners flavodoxin reductase and cobalamin-dependent methionine synthase

  2001cited by this paper
• Microsomal p450s use specific proline-rich sequences for efficient folding, but not for maintenance of the folded structure.

  2001cited by this paper
• Insertional Mutagenesis in then-Alkane-Assimilating Yeast Yarrowia lipolytica: Generation of Tagged Mutations in Genes Involved in Hydrophobic Substrate Utilization

  2001cited by this paper
• Crystal structure of Escherichia coli Fdx, an adrenodoxin-type ferredoxin involved in the assembly of iron-sulfur clusters.

  2001cited by this paper
• Uncommon P450-catalyzed reactions.

  2001cited by this paper
• Importance of a proline-rich sequence in the amino-terminal region for correct folding of mitochondrial and soluble microbial p450s.

  2001cited by this paper
• Putative helix F contributes to regioselectivity of hydroxylation in mitochondrial cytochrome P450 27A1.

  2001cited by this paper
• Vectors for gene expression and amplification in the yeast Yarrowia lipolytica

  2001cited by this paper
• CYP11A1 stimulates the hydroxylase activity of CYP11B1 in mitochondria of recombinant yeast in vivo and in vitro.

  2001cited by this paper
• Revelation of ternary complexes between redox partners in cytochrome P450-containing monooxygenase systems by the optical biosensor method.

  2001cited by this paper
• Steroidogenic enzyme gene expression in the human heart.

  2000cited by this paper
• The tertiary structure of full-length bovine adrenodoxin suggests functional dimers.

  2000cited by this paper
• Cytochromes P450: a success story

  2000cited by this paper
• Dual metabolic pathway of 25-hydroxyvitamin D3 catalyzed by human CYP24.

  2000cited by this paper
• Comparison of promoters suitable for regulated overexpression of β-galactosidase in the alkane-utilizing yeastYarrowia lipolytica

  2000cited by this paper
• Evidence for the cluster model of mitochondrial steroid hydroxylase system derived from dissociation constants of the complex between adrenodoxin reductase and adrenodoxin.

  2000cited by this paper
• Probing the NADPH-binding site of Escherichia coli flavodoxin oxidoreductase

  2000cited by this paper
• Interaction of Catalytic Domains in Cytochrome P450scc–Adrenodoxin Reductase–Adrenodoxin Fusion Protein Imported into Yeast Mitochondria

  2000cited by this paper
• Roles of NADPH-P450 reductase in the O-deethylation of 7-ethoxycoumarin by recombinant human cytochrome P450 1B1 variants in Escherichia coli.

  2000cited by this paper
• Development of a simple and rapid assay for the evaluation of inhibitors of human 17alpha-hydroxylase-C(17,20)-lyase (P450cl7) by coexpression of P450cl7 with NADPH-cytochrome-P450-reductase in Escherichia coli.

  2000cited by this paper
• Androsterone 3beta-substituted derivatives as inhibitors of type 3 17beta-hydroxysteroid dehydrogenase.

  2000cited by this paper
• Mammalian microsomal cytochrome P450 monooxygenase: structural adaptations for membrane binding and functional diversity.

  2000cited by this paper
• Novel imidazolyl and triazolyl substituted biphenyl compounds: synthesis and evaluation as nonsteroidal inhibitors of human 17alpha-hydroxylase-C17, 20-lyase (P450 17).

  2000cited by this paper
• Biochemical characterization of rat P450 2C11 fused to rat or bacterial NADPH-P450 reductase domains.

  2000cited by this paper
• Adrenodoxin: Structure, stability, and electron transfer properties

  2000cited by this paper
• Construction and characterization of a catalytic fusion protein system: P-450(11beta)-adrenodoxin reductase-adrenodoxin.

  2000cited by this paper
• On the effect of cholesterol on the fate of CYP11A1 imported into yeast mitochondria in vivo.

  2000cited by this paper
• Probing the NADPH-binding site of Escherichia coli flavodoxin oxidoreductase.

  2000cited by this paper
• Androsterone 3β-substituted derivatives as inhibitors of type 3 17β-hydroxysteroid dehydrogenase

  2000cited by this paper
• N-terminal Tail Export from the Mitochondrial Matrix

  1999cited by this paper

• Pregnenolone Bioproduction in Engineered Methylobacteria: Design and Elaboration

  2025cites this paper
• Optimization of Human STARD3 Cholesterol Transporter Expression for Enhancing Bovine P450scc-Mediated Steroid Biotransformation in E. coli.

  2025cites this paper
• Using of transporter proteins to improve the uptake efficiency of hydrophobic compounds by Escherichia coli: a coordinated synthesis of START protein and P450scc system proteins to enhance cholesterol biotransformation

  2025cites this paper
• Synthesis and In Silico Prediction of Biological Activity and Acute Toxicity of [1,3]Thiazolo[3,2-a]pyrimidines Containing Aliphatic Aldehyde Fragments

  2022cites this paper
• Analysis of Activity of Human Steroidogenic Acute Regulatory Protein (STARD1) Expressed in Escherichia coli Cells

  2022cites this paper
• Synthesis of triazole-containing ciprofloxacin conjugate and its in silico test as a cytochrome P450 ligand

  2021cites this paper
• Recombinant Yarrowia lipolytica strains for the heterologous expression of multi-component enzyme systems: Expression of mammalian steroidogenic proteins.

  2021cites this paper
• Using a viral 2A peptide-based strategy to reconstruct the bovine P450scc steroidogenic system in S. cerevisiae: Bovine P450scc system expression using 2A peptides.

  2020cites this paper
• [Synthesis and evaluation of N-alkynylaminosteroids as potential CYP450 17A1 inhibitors].

  2019cites this paper
• Synthesis and Evaluation of N-Alkynylaminosteroids as Potential Inhibitors of CYP450 17A1

  2019cites this paper
• Analysis of In Vivo Activity of the Bovine Cholesterol Hydroxylase/Lyase System Proteins Expressed in Escherichia coli

  2019cites this paper
• Steroidogenic Acute Regulatory Protein: Structure, Functioning, and Regulation

  2019cites this paper
• Protein Engineering of the Progesterone Hydroxylating P450‐Monooxygenase CYP17A1 Alters Its Regioselectivity

  2018cites this paper
• Polycistronic expression of the mitochondrial steroidogenic P450scc system in the HEK293T cell line

  2018influential citation
• In Vitro and In Vivo characterization of CYP11A1, CYP17A1 and cChloramphenicol acetyltransferase-dependent steroid conversion

  2015cites this paper
• Features of terahertz adsorption and Raman scattering of mineralocorticoid hormones

  2015cites this paper
• Yarrowia lipolytica: recent achievements in heterologous protein expression and pathway engineering

  2015cites this paper
• A gene recombination method for machine tools design based on complex network

  2015cites this paper
• IN VITRO AND IN VIVO CHARACTERIZATION OF CYP 11 A 1 , CYP 17 A 1 AND CHLORAMPHENICOL ACETYLTRANSFERASE-DEPENDENT STEROID CONVERSION

  2015cites this paper
• Superoxide dismutase activity in transgenic canola

  2014cites this paper
• Functional Activity of Rat Adrenocorticocytes after Incubation in Dimethyl Sulfoxide Based Cryoprotective Media Supplemented with Fetal Bovine Serum

  2014cites this paper
• Evaluation of the fluorescent probes Nile Red and 25‐NBD‐cholesterol as substrates for steroid‐converting oxidoreductases using pure enzymes and microorganisms

  2013cites this paper
• Functional reconstruction of bovine P450scc steroidogenic system in Escherichia coli

  2013cites this paper
• Cytochrome P450 Expression in Yarrowia lipolytica and Its Use in Steroid Biotransformation

  2013cites this paper
• Cytochromes P450 of the Alkane-Utilising Yeast Yarrowia lipolytica

  2013cites this paper
• 16α-Hydroxycholic Acid: In Vivo Microbial Transformation Product of Cholic Acid

  2013cites this paper
• Steroid biotransformations in biphasic systems with Yarrowia lipolytica expressing human liver cytochrome P450 genes

  2012cites this paper
• 22-NBD-cholesterol, a new fluorescent substrate of bacterial cholesterol-oxidases

  2012cites this paper
• Microbial steroid transformations: current state and prospects

  2012cites this paper
• Production of human cytochrome P450 2D6 drug metabolites with recombinant microbes--a comparative study.

  2012cites this paper